Highlights from 2022 in EHJ Open

Magnus Bäck^{1

2

3}, Maciej Banach⁴, Frieder Braunschweig^{1

2}, Salvatore De Rosa⁵, Alessia Gimelli⁶, Thomas Kahan^{7

8}, Daniel F J Ketelhuth⁹, Patrizio Lancellotti¹⁰, Susanna C Larsson^{11

12}, Linda Mellbin^{1

2}, Edit Nagy^{1

2}, Gianluigi Savarese^{1

2}, Karolina Szummer^{1

13}, Denis Wahl³; European Heart Journal Open Section Editors

Affiliations

¹ Department of Cardiology, Heart and Vascular Center, Karolinska University Hospital, 17177 Stockholm, Sweden.
² Department of Medicine Solna, Karolinska Institutet, 17177 Stockholm, Sweden.
³ Nancy University Hospital, University of Lorraine and INSERM U1116, 54511 Nancy, France.
⁴ Department of Preventive Cardiology and Lipidology, Medical University of Lodz and Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
⁵ Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
⁶ Cardiovascular and Imaging Departments, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
⁷ Department of Cardiology, Danderyd University Hospital, Stockohlm, Sweden.
⁸ Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
⁹ Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
¹⁰ GIGA Cardiovascular Sciences, University of Liège Hospital, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium.
¹¹ Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹² Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
¹³ Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Editorial

Magnus Bäck et al. Eur Heart J Open. 2022.

. 2022 Dec 30;2(6):oeac084.

doi: 10.1093/ehjopen/oeac084. eCollection 2022 Nov.

¹ Department of Cardiology, Heart and Vascular Center, Karolinska University Hospital, 17177 Stockholm, Sweden.
² Department of Medicine Solna, Karolinska Institutet, 17177 Stockholm, Sweden.
³ Nancy University Hospital, University of Lorraine and INSERM U1116, 54511 Nancy, France.
⁴ Department of Preventive Cardiology and Lipidology, Medical University of Lodz and Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
⁵ Division of Cardiology, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
⁶ Cardiovascular and Imaging Departments, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
⁷ Department of Cardiology, Danderyd University Hospital, Stockohlm, Sweden.
⁸ Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
⁹ Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
¹⁰ GIGA Cardiovascular Sciences, University of Liège Hospital, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium.
¹¹ Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹² Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
¹³ Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

No abstract available

References

1. Cremer PC, Sheng CC, Sahoo D, Dugar S, Prada RA, Wang TKM, Hassan OKA, Hernandez-Montfort J, Wolinsky DA, Culver DA, Rajendram P, Duggal A, Brennan DM, Wolski KE, Lincoff AM, Nissen SE, Menon V. Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. Eur Heart J Open 2021;1:oeab002. - PMC - PubMed
1. Bartholomew CL, Muhlestein JB, May HT, Le VT, Galenko O, Garrett KD, Brunker C, Hopkins RO, Carlquist JF, Knowlton KU, Anderson JL, Bailey BW, Horne BD. Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial. Eur Heart J Open 2021;1:oeab026. - PMC - PubMed
1. Funamoto M, Sunagawa Y, Katanasaka Y, Kato T, Funada J, Ajiro Y, Komiyama M, Akao M, Yasoda A, Yamakage H, Satoh-Asahara N, Wada H, Ikeda Y, Morimoto T, Hasegawa K. Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study. Eur Heart J Open 2022;2:oeac057. - PMC - PubMed
1. Svennberg E, Braunschweig F. Screening for atrial fibrillation: less is more? Eur Heart J Open 2021;1:oeab038. - PMC - PubMed
1. McIntyre WF, Diederichsen SZ, Freedman B, Schnabel RB, Svennberg E, Healey JS. Screening for atrial fibrillation to prevent stroke: a meta-analysis. Eur Heart J Open 2022;2:oeac044. - PMC - PubMed